
FDA issues warning letter to AcelRx Pharmaceuticals, Inc.
Feb 16 - Regarding false and misleading claims about Dsuvia sublingual tablet
Ranging from the acceleration of development for treatments for COVID-19, maintaining and securing drug supply chains, providing guidance to manufacturers, advising developers on how to handle clinical trial issues, and keeping the public informed
Learn MoreFeb 16 - Regarding false and misleading claims about Dsuvia sublingual tablet
Feb 16 - FDA provides guidance on early development for anti-cancer therapies
Feb 12 - To reduce bone marrow suppression caused by chemotherapy
FAQs about hand sanitizers. Find drug information. Report drug side effects. Learn how to buy, use, and dispose of unused drugs. Attend a public meeting.
Get drug safety, recall, and shortage information. Report drug adverse events. Find jobs at FDA. Watch training/education videos and courses.
Search drug databases. Find guidance, submission, user fee, and meeting information. Get small business assistance. Find jobs at FDA.
Feb 15
Feb 02
Jan 27
Your source for the latest drug information.
Know the moment it happens.